- Home
- RM vs DRTS Comparison
RM vs DRTS Comparison
Compare RM & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RM
- DRTS
- Stock Information
- Founded
- RM 1987
- DRTS 2015
- Country
- RM United States
- DRTS Israel
- Employees
- RM N/A
- DRTS N/A
- Industry
- RM Finance: Consumer Services
- DRTS Medical/Dental Instruments
- Sector
- RM Finance
- DRTS Health Care
- Exchange
- RM Nasdaq
- DRTS Nasdaq
- Market Cap
- RM 282.1M
- DRTS 262.6M
- IPO Year
- RM 2012
- DRTS N/A
- Fundamental
- Price
- RM $26.06
- DRTS $2.98
- Analyst Decision
- RM Hold
- DRTS Strong Buy
- Analyst Count
- RM 3
- DRTS 2
- Target Price
- RM $30.00
- DRTS $8.00
- AVG Volume (30 Days)
- RM 50.3K
- DRTS 51.5K
- Earning Date
- RM 07-30-2025
- DRTS 05-19-2025
- Dividend Yield
- RM 4.54%
- DRTS N/A
- EPS Growth
- RM 41.13
- DRTS N/A
- EPS
- RM 3.29
- DRTS N/A
- Revenue
- RM $577,647,000.00
- DRTS N/A
- Revenue This Year
- RM $13.10
- DRTS N/A
- Revenue Next Year
- RM $9.35
- DRTS N/A
- P/E Ratio
- RM $8.03
- DRTS N/A
- Revenue Growth
- RM 6.45
- DRTS N/A
- 52 Week Low
- RM $25.41
- DRTS $1.75
- 52 Week High
- RM $37.52
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- RM 33.92
- DRTS 54.53
- Support Level
- RM $26.16
- DRTS $2.92
- Resistance Level
- RM $27.01
- DRTS $3.12
- Average True Range (ATR)
- RM 0.71
- DRTS 0.19
- MACD
- RM -0.15
- DRTS -0.01
- Stochastic Oscillator
- RM 0.00
- DRTS 30.00
About RM Regional Management Corp.
Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.